Idenix Pharmaceuticals Reports Second Quarter and Six Month 2014 Financial Results
July 31, 2014 16:30 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., July 31, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
Idenix Pharmaceuticals Reports First Quarter 2014 Financial Results and HCV Pipeline Review
May 01, 2014 16:05 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., May 1, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
Idenix Pharmaceuticals to Present at Three Upcoming Healthcare Conferences
April 30, 2014 08:00 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., April 30, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), announced today that Idenix management will host a fireside chat at the Deutsche Bank Securities 39th...
Idenix Announces Promising Clinical Data and Continued Progress in Nucleotide Prodrug Development Programs for the Treatment of Hepatitis C
April 07, 2014 07:00 ET
|
Idenix Pharmaceuticals
Idenix Reports Positive Proof-of-Concept Data for Lead Nucleotide Prodrug, IDX21437
Idenix on Track to Initiate All-Oral Pan-Genotypic Phase II Combination Clinical Study of IDX21437 and...
Idenix Announces Nucleotide Prodrug (IDX21437) and NS5A Inhibitor (Samatasvir) Poster Presentations at 49th Annual Meeting of the European Association for the Study of the Liver
March 24, 2014 08:00 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., March 24, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of...
Idenix Pharmaceuticals Intends to Appeal Norway District Court Decision Regarding Patent Invalidity Case
March 24, 2014 07:00 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., March 24, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of...
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe
March 14, 2014 07:00 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., March 14, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of...
Idenix Pharmaceuticals Reports Fourth Quarter and Year Ended 2013 Financial Results
February 27, 2014 16:05 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Feb. 27, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
Idenix Pharmaceuticals to Present at Two Upcoming Healthcare Conferences
February 26, 2014 08:00 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Feb. 26, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present at the Cowen & Company 34th Annual Health Care...
Idenix Pharmaceuticals to Present at the 2014 Leerink Global Healthcare Conference
February 07, 2014 08:30 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Feb. 7, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will participate in a fireside chat discussion at the 2014 Leerink...